# Xoft® Intraoperative Radiotherapy (IORT) for Patients With Early-Stage Breast Cancer

> **NCT04088435** · — · TERMINATED · sponsor: **University of Louisville** · enrollment: 10 (actual)

## Conditions studied

- Breast Cancer
- Breast Cancer, Invasive Ductal
- Invasive Mammary Carcinoma
- Breast Cancer Stage I
- Breast Cancer Stage IIA

## Interventions

- **RADIATION:** Intraoperative radiotherapy

## Key facts

- **NCT ID:** NCT04088435
- **Lead sponsor:** University of Louisville
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2019-09-10
- **Primary completion:** 2022-06-05
- **Final completion:** 2022-06-05
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Low accrual
- **Last updated:** 2023-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04088435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04088435, "Xoft® Intraoperative Radiotherapy (IORT) for Patients With Early-Stage Breast Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04088435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*